ʻaoʻao_banner

Posaconazole waena

  • (5R-cis)-Toluene-4-sulfonic acid 5-(2,4-difluorophenyl)-5-(1H-1,2,4-triazol-1-yl)methyltetrahydrofuran-3-ylmethyl ester

    (5R-cis)-Toluene-4-sulfonic acid 5-(2,4-difluorophenyl)-5-(1H-1,2,4-triazol-1-yl)methyltetrahydrofuran-3-ylmethyl ester

    Mea Kimia & Kino

    Posaconazole waena.

    ʻO Posaconazole, i hoʻokuʻu ʻia ma UK, ʻo ia ka lālā hou o ka papa azole o nā mea antifungal e hiki ai i ka mākeke.Hōʻike ʻia ia no ka mālama ʻana a me ka prophylaxis o kahi ʻano o nā maʻi fungal invasive, me ka aspergillosis, fusariosis, chromoblastomycosis, mycetoma, a me ka coccidiomycosis i nā poʻe maʻi e kūpaʻa ʻole, a intolerant paha i ka lāʻau maʻamau me amphotericin B a / a itraconazole.Ma US, ua ʻae ʻia ia no ka prophylaxis o nā maʻi invasive Aspergillus a me Candida i nā maʻi 13 mau makahiki i ka nui o ka pilikia o ka hoʻomohala ʻana i kēia mau maʻi ma muli o ka loaʻa ʻana o ka immunocompromised.Eia kekahi, ua ʻae ʻia no ka mālama ʻana i ka candidiasis oropharyngeal.Loaʻa i ka Posaconazole kahi kikoʻī o ka hana ma luna o nā lālā ʻē aʻe o ka azole antifungals.Ma kahi o ka hana ikaika e kū'ē i nā hihia refractory o ka aspergillosis a me ka fluconazole-resistant Candida, hōʻike ia i ka hana kūʻē iā Zygomycetes.

    Inā makemake ʻoe i kā mākou huahana a i ʻole he nīnau, e ʻoluʻolu e hoʻokaʻaʻike mai iā mākou!

    Hāʻawi ʻia nā huahana ma lalo o ka patent no ke kumu R&D wale nō.

  • 2-[(1S,2S)-1-ethyl-2-bezyloxypropyl]-2,4-dihydro-4-[4-[4-(4-hydroxyphenyl)-1-piperazinyl]phenyl]- 3H-1,2 ,4-Triazol-3-kahi

    2-[(1S,2S)-1-ethyl-2-bezyloxypropyl]-2,4-dihydro-4-[4-[4-(4-hydroxyphenyl)-1-piperazinyl]phenyl]- 3H-1,2 ,4-Triazol-3-kahi

    Mea Kimia & Kino

    Ma waena o ka hoʻomākaukau ʻana o Posaconazole.

    Inā makemake ʻoe i kā mākou huahana a i ʻole he nīnau, e ʻoluʻolu e hoʻokaʻaʻike mai iā mākou!

    Hāʻawi ʻia nā huahana ma lalo o ka patent no ke kumu R&D wale nō.